PNC Financial Services Group’s Ligand Pharmaceuticals LGND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$188K Sell
1,656
-374
-18% -$42.5K ﹤0.01% 2252
2025
Q1
$213K Sell
2,030
-71
-3% -$7.47K ﹤0.01% 2138
2024
Q4
$225K Buy
2,101
+69
+3% +$7.39K ﹤0.01% 2113
2024
Q3
$203K Sell
2,032
-14
-0.7% -$1.4K ﹤0.01% 2160
2024
Q2
$172K Sell
2,046
-165
-7% -$13.9K ﹤0.01% 2260
2024
Q1
$162K Buy
2,211
+371
+20% +$27.1K ﹤0.01% 2326
2023
Q4
$131K Buy
1,840
+450
+32% +$32.1K ﹤0.01% 2431
2023
Q3
$83.3K Sell
1,390
-155
-10% -$9.29K ﹤0.01% 2680
2023
Q2
$111K Sell
1,545
-20
-1% -$1.44K ﹤0.01% 2584
2023
Q1
$115K Buy
1,565
+130
+9% +$9.56K ﹤0.01% 2478
2022
Q4
$95.9K Sell
1,435
-601
-30% -$40.1K ﹤0.01% 2583
2022
Q3
$110K Buy
2,036
+633
+45% +$34.2K ﹤0.01% 2472
2022
Q2
$78K Sell
1,403
-533
-28% -$29.6K ﹤0.01% 2736
2022
Q1
$135K Buy
1,936
+118
+6% +$8.23K ﹤0.01% 2518
2021
Q4
$175K Buy
1,818
+201
+12% +$19.3K ﹤0.01% 2329
2021
Q3
$141K Buy
1,617
+599
+59% +$52.2K ﹤0.01% 2409
2021
Q2
$84K Sell
1,018
-38
-4% -$3.14K ﹤0.01% 2757
2021
Q1
$101K Buy
1,056
+107
+11% +$10.2K ﹤0.01% 2573
2020
Q4
$60K Sell
949
-394
-29% -$24.9K ﹤0.01% 2786
2020
Q3
$80K Sell
1,343
-161
-11% -$9.59K ﹤0.01% 2444
2020
Q2
$105K Sell
1,504
-234
-13% -$16.3K ﹤0.01% 2296
2020
Q1
$79K Sell
1,738
-263
-13% -$12K ﹤0.01% 2354
2019
Q4
$129K Buy
2,001
+255
+15% +$16.4K ﹤0.01% 2342
2019
Q3
$108K Sell
1,746
-1,832
-51% -$113K ﹤0.01% 2491
2019
Q2
$254K Buy
3,578
+420
+13% +$29.8K ﹤0.01% 2029
2019
Q1
$249K Buy
3,158
+50
+2% +$3.94K ﹤0.01% 2015
2018
Q4
$263K Sell
3,108
-44,083
-93% -$3.73M ﹤0.01% 1896
2018
Q3
$8.08M Sell
47,191
-16,261
-26% -$2.78M 0.01% 604
2018
Q2
$8.2M Buy
63,452
+95
+0.1% +$12.3K 0.01% 596
2018
Q1
$6.53M Sell
63,357
-290
-0.5% -$29.9K 0.01% 639
2017
Q4
$5.44M Buy
63,647
+19,941
+46% +$1.7M 0.01% 702
2017
Q3
$3.71M Buy
43,706
+27,716
+173% +$2.35M ﹤0.01% 813
2017
Q2
$1.21M Buy
15,990
+774
+5% +$58.6K ﹤0.01% 1183
2017
Q1
$1.01M Sell
15,216
-6,918
-31% -$457K ﹤0.01% 1290
2016
Q4
$1.4M Sell
22,134
-7,170
-24% -$454K ﹤0.01% 1140
2016
Q3
$1.87M Sell
29,304
-662
-2% -$42.2K ﹤0.01% 1015
2016
Q2
$2.23M Buy
29,966
+442
+1% +$32.9K ﹤0.01% 896
2016
Q1
$1.97M Buy
29,524
+9,281
+46% +$620K ﹤0.01% 943
2015
Q4
$1.37M Buy
20,243
+239
+1% +$16.2K ﹤0.01% 1070
2015
Q3
$1.07M Buy
20,004
+388
+2% +$20.8K ﹤0.01% 1201
2015
Q2
$1.23M Buy
19,616
+4,117
+27% +$259K ﹤0.01% 1190
2015
Q1
$745K Buy
15,499
+3,680
+31% +$177K ﹤0.01% 1385
2014
Q4
$392K Sell
11,819
-5,740
-33% -$190K ﹤0.01% 1673
2014
Q3
$515K Sell
17,559
-4,625
-21% -$136K ﹤0.01% 1462
2014
Q2
$862K Sell
22,184
-1,669
-7% -$64.9K ﹤0.01% 1146
2014
Q1
$1M Buy
23,853
+2,605
+12% +$109K ﹤0.01% 1073
2013
Q4
$697K Sell
21,248
-11,184
-34% -$367K ﹤0.01% 1190
2013
Q3
$876K Sell
32,432
-5,110
-14% -$138K ﹤0.01% 1062
2013
Q2
$876K Buy
+37,542
New +$876K ﹤0.01% 1030